In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

Cathie Wood is known for seizing opportunities. The founder of Ark Invest doesn't worry when one of the stocks she's invested ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

CRISPR stock offers bold investment potential and how strategic portfolio management can boost resilience and long-term ...

CRISPR Therapeutics CRSP and Beam Therapeutics BEAM are leading developers of therapies that utilize the Nobel Prize-winning CRISPR/Cas9 gene editing technology. While CRSP is the first and only ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of its in-vivo candidate, CTX310, as well as better-than-expected sales of ...

On the selling side, ARK divested from DraftKings Inc (NASDAQ:DKNG), offloading a total of 266,052 shares across the same three ETFs for a total value of nearly $12.69 million. This sale marks a ...

A live webcast will be available on the "Events & Presentations" page in the Investors section of the Company's website at ...